| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Imagenebio, Inc. (IMA) has 9 insiders with recent SEC Form 4 filings, including 11 buys and 11 sells. IMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 336.6K | $1.82M | - | |
| CEO | 238.9K | $1.29M | - | |
| Other | 55.6K | $301.3K | -3,196 | |
| Dir | 31.2K | $169.1K | - | |
| Other | 25.6K | $138.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | Lally Robert B | Principal Accounting Officer | Sell | 3,196 | $5.42 | $17,334.00 | -2.8% | - | - | |
| Dec 24, 2025 | Slattery Joseph P | Director | Buy | 16,000 | $5.99 | $95,840.00 | New | -7.5% | - | |
| Jul 25, 2025 | Stampacchia Otello | - | Buy | 267,556 | $29.90 | $7,999,924.40 | +142.8% | -56.9% | -67.4% | |
| Jul 25, 2025 | Bonita David P64 | - | Buy | 83,611 | $29.90 | $2,499,968.90 | +40.9% | -56.9% | -67.4% | |
| Jun 24, 2022 | Bonita David P64 | Director | Buy | 252,225 | $4.47 | $1,128,020.79 | +3.3% | -35.6% | +28.5% | |
| Jun 24, 2022 | Orbimed Advisors LLC66 | Director | Buy | 252,225 | $4.47 | $1,128,020.79 | +3.3% | -35.6% | +28.5% | |
| Jan 11, 2022 | Zhang Xiaoyan Michelle79 | Chief Scientific Officer | Sale+OE | 1,000 | $12.00 | $12,000.00 | -1.1% | -43.8% | -74.7% | |
| Dec 14, 2021 | Formela Jean Francois70 | Director | Sell | 26,278 | $14.67 | $385,571.87 | -0.7% | -59.2% | -80.1% | |
| Dec 14, 2021 | Atlas Venture Fund Xi, L.P.53 | 10% Owner | Sell | 26,278 | $14.67 | $385,571.87 | -0.7% | -59.2% | -80.1% | |
| Dec 10, 2021 | Zhang Xiaoyan Michelle79 | Chief Scientific Officer | Sale+OE | 1,000 | $14.76 | $14,759.90 | -2.2% | -55.3% | -79.5% |